Onco-Connect: Redefining Cancer Care

Onco-Connect; Integrated Oncology Platform

Second Opinions I Medical Travel I Cancer Medicines

Onco-Connect; a digital enterprise to improve global access and choice whilst maintaining high-quality standards of cancer care.

Onco-Connect believes that world class cancer care should be accessible to all, especially within the urban and rural landscapes of the developing world. We connect communities to renowned consultants and institutions of Germany, India, Singapore & United Kingdom.

The founders of Onco-Connect quit their high-profile jobs in London and moved to Mumbai to start this enterprise, with the aim to reach every country & every segment of society irrespective of their differences or similarities.

Onco-Connect provides complete cancer care where everyone can get access to the latest technology, research and new advances in cancer treatment. Partnering with renowned & prestigious institutions improves choices for treatment and opinions. Innovative approach through digital second opinions; medical travel in accordance to the country of choice & affordable care were the reasons to start this enterprise.

Empowering patients is vital to forming successful treatment and long term partnerships. Onco-Connect would empower patients with information and knowledge to make their choice for prevention, screening & treatment of their cancer.

Onco-Connect is proud to receive recognition as a Start Up India Initiative by the Government of India.

Neha Vora & Atul Kulkarni

Founders & Directors

Onco-Connect; Launched on 19.01.2019

Contact us:

E: neha.vora@onco-connect.com I atul.kulkarni@onco-connect.com

T: +91 9820237167

Company Details:

CrossRoads Health Services Pvt Ltd venture

E: info@onco-connect.com


Photo can be made available on request. https://onco-connect.com

Press release distributed by Pressat on behalf of ONCO-CONNECT, on Sunday 3 March, 2019. For more information subscribe and follow https://pressat.co.uk/

Cancer Second Opinion Medical Travel Cancer Medicines Information & Support Business & Finance Health Medical & Pharmaceutical
Published By


+91 9820237167
Visit Newsroom


* For more information regarding media usage, ownership and rights please contact ONCO-CONNECT.

Additional PR Formats

You just read:

Onco-Connect: Redefining Cancer Care